Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7456 AL 7470

Six-membered N-heterocyclic alkaloids as ChE inhibitors in alzheimer's disease treatment

Yadav P, Dabas A, Singh R.

Metab Brain Dis. 2025 Nov 6;40(8):309. doi: 10.1007/s11011-025-01740-5.

Behavioral dyadic interventions in the context of Alzheimer's disease and related dementia: A call to action

Vranceanu AM, Szapary CL, Cornelius T, Monin JK, Syme M, Okereke OI, Lyons KS, Plys E.

J Alzheimers Dis. 2026 Jan;109(1):34-43. doi: 10.1177/13872877251392184. Epub 2025 Nov 10.

Targeted Nanoparticles for Drug Delivery Across the Blood-Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review

Kochman U, Sitka H, Kuźniar J, Czaja M, Kozubek P, Beszłej JA, Leszek J.

Mol Neurobiol. 2025 Nov 19;63(1):75. doi: 10.1007/s12035-025-05417-z.

Beyond Estrogen: Unraveling the Complexities of Hormonal Signaling Pathways in Alzheimer's Disease and Their Implications for Precision Therapy

Mohammed SN, Direksunthorn T, Zwamel AH, Uthirapathy S, Ballal S, Kalia R, Arya R, Naidu KS, Ahmad I, Ahmed JK.

Mol Neurobiol. 2025 Nov 19;63(1):77. doi: 10.1007/s12035-025-05338-x.

[Aging, β-amyloid, Alzheimer's - Opinion]

Stępkowski D, Jarmuła A.

Postepy Biochem. 2025 May 26;71(2):187-190. doi: 10.18388/pb.2021_608. Print 2025 Jun 30.

Pharmacological Regulation of Mitophagy by Natural Plant Products as a Therapeutic Target for Alzheimer's Disease

Shao S, Lu H, Zu R, Chen Y, Peng Z, Peng Q, Ma H, Sun Y.

Phytother Res. 2026 Jan;40(1):248-266. doi: 10.1002/ptr.70131. Epub 2025 Nov 21.

Recent advances in bioisosteric modifications for targeting Alzheimer's disease pathways

Verma A, Waiker DK, Gupta PS, Shrivastava SK.

Bioorg Chem. 2025 Dec;167:109248. doi: 10.1016/j.bioorg.2025.109248. Epub 2025 Nov 13.

Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer's disease treatment

Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Shokr MM, Alexiou A, Papadakis M, Batiha GE.

Inflammopharmacology. 2026 Jan;34(1):267-283. doi: 10.1007/s10787-025-02000-9. Epub 2025 Nov 26.

Sirtuins in Alzheimer's disease: mechanistic insights and therapeutic opportunities

Bai N, Liu S, Wei J, Zheng B, Wang W, Li X, Yang J, Song X, Wang L, Yi F, Cao L.

Trends Pharmacol Sci. 2026 Jan;47(1):100-119. doi: 10.1016/j.tips.2025.10.016. Epub 2025 Nov 26.

Multitarget-directed ligands in Alzheimer's disease: identification of AChE and BACE1 inhibitors by in silico approaches

da Conceição RA, Barbosa MLC, de Souza AMT.

J Comput Aided Mol Des. 2025 Dec 3;40(1):7. doi: 10.1007/s10822-025-00712-2.

Targeting protein kinase C signaling cascades in alzheimer's disease: emerging neuroprotective roles of aurothioglucose

Kushawaha SK, Vashisht K, Kumar H, Ashawat MS, Baldi A.

Inflammopharmacology. 2026 Jan;34(1):243-254. doi: 10.1007/s10787-025-02077-2. Epub 2025 Dec 3.

The therapeutic potential of early exercise in Alzheimer's disease: Focus on the brain-spleen axis

Wang T, Feng L, Tian Z.

Ageing Res Rev. 2026 Jan;114:102980. doi: 10.1016/j.arr.2025.102980. Epub 2025 Dec 1.

Effects of plant-derived dietary antioxidants on Alzheimer's disease: Focus on ferroptosis

Gu F, Zhu J, Zhu P, Zou Z.

Asia Pac J Clin Nutr. 2025 Dec;34(6):922-940. doi: 10.6133/apjcn.202512_34(6).0007.

The Role and Therapeutic Potential of the cGAS-STING Signaling Pathway in Alzheimer's Disease

Li X, Gao W, Ye Q, Li H.

Brain Behav. 2025 Dec;15(12):e71130. doi: 10.1002/brb3.71130.

Neuroprotective potential of Rhus coriaria: Insights into acetylcholinesterase inhibition and amyloid-β modulation

Ahmed A, Khan H, Shen Y, Xu S, Zhao Y, Lv J, Zhu X, Fu X, Li P.

J Alzheimers Dis. 2026 Feb;109(3):1053-1067. doi: 10.1177/13872877251404020. Epub 2025 Dec 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias